Therapeutics: Granulocyte macrophage colony-stimulating factor (GM-CSF; CSF2); toll-like receptor 9 (TLR9)

Mouse studies suggest a vaccine based on tumor cells, GM-CSF and a TLR9 agonist could help treat melanoma. The vaccine consisted of irradiated human melanoma cells, GM-CSF and a TLR9 agonist encapsula...